Atrium Health Levine Cancer Institute
36
20
26
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 40/100
8.3%
3 terminated/withdrawn out of 36 trials
66.7%
-19.8% vs industry average
3%
1 trials in Phase 3/4
83%
5 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (36)
A Study Evaluating the Effect of Frozen-Section Directed Excision Surgery on Vulvar Dysplasia
Role: collaborator
Trial of Anastrozole and Palbociclib in Metastatic HER2-Negative Breast Cancer
Role: collaborator
Assessing and Addressing Health-Related Social Needs Among Families of Children With Cancer
Role: collaborator
Immune Signature Analysis of Disease Progression in Post Immunotherapy Lung Cancer Patients
Role: collaborator
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer
Role: collaborator
Nivolumab in Multiple Myeloma Patients After Idecabtagene Vicleucel
Role: collaborator
Pre-malignant States to Hematologic Malignancies in Firefighters
Role: collaborator
Pharmacogenomic Testing in Pediatric Hematology/Oncology Patients
Role: collaborator
Utility of a Mobile Application for Young Women With Breast Cancer
Role: collaborator
ONC-MM-2407: The Effect of Virtual Reality Headsets on Pain and Anxiety in the Peri and Post Bone Marrow Biopsy Period
Role: collaborator
LCI-HEM-MYE-CRD-002: Carfilzomib-Revlimid-Dexamethasone-Elotuzumab in Relapsed/Refractory Multiple Myeloma
Role: collaborator
Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma
Role: collaborator
Evaluation of the Pathobiology of CALR-mutated MPN Cells
Role: collaborator
ONC-LEUK-2406: The Impact of Systematic Financial Navigation in Acute Myeloid Leukemia
Role: collaborator
Use of High Dose Radiation Followed by Chemotherapy and Radiation to Treat Locally Advanced NSCLC
Role: collaborator
Cancer-related Fatigue During Maintenance Immunotherapy for Non-small Cell Lung Cancer (NSCLC): a Qualitative Study
Role: collaborator
Toxicity Genetic Determinants and Response to Azacitidine and Venetoclax in AML
Role: collaborator
Patient Descriptors Of Cancer-Related Fatigue: A Mixed Methods Pilot Study Of Cancer Survivors
Role: collaborator
Evaluating Microarray Pharmacogenetic Testing in Cancer Patients
Role: collaborator
Discharge Medication Use Post-Operatively in GU Cancer Patients
Role: collaborator